First Mercantile Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

First Mercantile Trust’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$64K	Sell	797 -45	-5%	-$3.89K	0.01%	748
2021 Q2	$82K	Sell	842 -55	-6%	-$6.51K	0.01%	739
2021 Q1	$105K	Sell	897 -79	-8%	-$9.21K	0.01%	667
2020 Q4	$109K	Sell	976 -70	-7%	-$8.56K	0.01%	664
2020 Q3	$133K	Buy	1,046 +358	+52%	+$38.9K	0.02%	575
2020 Q2	$78K	Buy	+688	New	+$67.7K	0.01%	736
2019 Q2	–	Sell	-789	Closed	-$99K	–	883
2019 Q1	$99K	Buy	789 +165	+26%	+$20.5K	0.02%	666
2018 Q4	$70K	Buy	624 +214	+52%	+$33.1K	0.02%	729
2018 Q3	$88K	Buy	+410	New	+$103K	0.02%	724

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Mercantile Trust's MDGL Position: Q3 2021 in Review

First Mercantile Trust reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.3% in Q3 2021, selling an estimated $3.89K and leaving 797 shares worth $64K. The position accounts for 0.01% of the portfolio, ranked #748.

First Mercantile Trust first reported a position in MDGL in Q3 2018 and has held it in 9 quarters since. The position peaked at $133K in Q3 2020. 133 funds tracked by Wall St. Rank hold MDGL as of Q3 2021.

First Mercantile Trust held 797 shares of Madrigal Pharmaceuticals worth $64K as of Q3 2021.
First Mercantile Trust sold 45 Madrigal Pharmaceuticals shares in Q3 2021, an estimated $3.89K.
Madrigal Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #748 holding.
First Mercantile Trust first reported a position in Madrigal Pharmaceuticals in Q3 2018 and has held it in 9 quarters since.
First Mercantile Trust's Madrigal Pharmaceuticals position peaked at $133K in Q3 2020.
133 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.